Genmab | GEN - Trade Creditors


Genmab reported DKK6M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Agios Pharmaceuticals USD 18.36M 1.2M Dec/2025
Almirall EUR 258.05M 58.66M Dec/2025
Amarin USD 45.36M 8.64M Dec/2025
Amgen USD 20.89B 1.25B Dec/2025
argenx SE USD 852.2M 369.5M Jun/2025
AstraZeneca USD 25.28B 252M Dec/2025
Bayer EUR 7.08B 700M Dec/2025
BioMarin Pharmaceutical USD 759.03M 39.41M Dec/2025
Demant DKK 923M 41M Dec/2025
Exelixis USD 29.62M 4.27M Dec/2025
Fresenius Medical Care EUR 835.55M 109.7M Dec/2025
Galapagos EUR 104.65M 4.02M Dec/2025
Genmab DKK 6M 2M Sep/2025
GlaxoSmithKline GBP 15.38B 294M Dec/2025
GN Store Nord DKK 1.5B 101M Dec/2025
GRIFOLS EUR 841M 37.68M Dec/2025
Hikma Pharmaceutical USD 715M 104M Dec/2025
Insmed USD 79.91M 316K Dec/2025
Lonza CHF 471M 3M Dec/2024
Merck EUR 2.11B 182M Dec/2025
Novartis USD 4.46B 99M Dec/2025
Regeneron Pharmaceuticals USD 5.83B 4.93B Dec/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
Sanofi EUR 22.93B 927M Dec/2025
UCB EUR 4.04B 755M Dec/2025